Oral ibuprofen and tetracycline for the treatment of acne vulgaris

R. C. Wong, Sewon Kang, J. L. Heezen, J. J. Voorhees, C. N. Ellis

Research output: Contribution to journalArticle

Abstract

A prospective evaluation of the efficacy and safety of oral ibuprofen and tetracycline hydrochloride was conducted for 8 weeks in patients with moderately severe acne. Sixty-eight patients were randomly assigned in a double-blind fashion to one of four regimens: (1) one 600 mg ibuprofen tablet plus one 250 mg tetracycline capsule four times daily; (2) one 600 mg ibuprofen tablet plus one placebo capsule four times daily; (3) one 250 mg tetracycline capsule plus one placebo tablet four times daily; and (4) one placebo tablet and one placebo capsule four times daily. Sixty patients completed the 8-week study. The mean percent improvement in the groups treated with ibuprofen and tetracycline (56% ± 5 SE), ibuproten alone (26% ± 13 SE), or tetracycline alone (26% ± 9 SE) was statistically significant. However, only the combination of ibuprofen and tetracycline therapy had an effect statistically better than the placebo response (16% ± 11 SE). Adverse effects were transient and were similar in all four groups.

Original languageEnglish (US)
Pages (from-to)1076-1081
Number of pages6
JournalJournal of the American Academy of Dermatology
Volume11
Issue number6
DOIs
StatePublished - 1984
Externally publishedYes

Fingerprint

Ibuprofen
Acne Vulgaris
Tetracycline
Placebos
Tablets
Capsules
Therapeutics
Safety

ASJC Scopus subject areas

  • Dermatology

Cite this

Oral ibuprofen and tetracycline for the treatment of acne vulgaris. / Wong, R. C.; Kang, Sewon; Heezen, J. L.; Voorhees, J. J.; Ellis, C. N.

In: Journal of the American Academy of Dermatology, Vol. 11, No. 6, 1984, p. 1076-1081.

Research output: Contribution to journalArticle

Wong, R. C. ; Kang, Sewon ; Heezen, J. L. ; Voorhees, J. J. ; Ellis, C. N. / Oral ibuprofen and tetracycline for the treatment of acne vulgaris. In: Journal of the American Academy of Dermatology. 1984 ; Vol. 11, No. 6. pp. 1076-1081.
@article{35214baf56264bf2b21a26fbba0761f0,
title = "Oral ibuprofen and tetracycline for the treatment of acne vulgaris",
abstract = "A prospective evaluation of the efficacy and safety of oral ibuprofen and tetracycline hydrochloride was conducted for 8 weeks in patients with moderately severe acne. Sixty-eight patients were randomly assigned in a double-blind fashion to one of four regimens: (1) one 600 mg ibuprofen tablet plus one 250 mg tetracycline capsule four times daily; (2) one 600 mg ibuprofen tablet plus one placebo capsule four times daily; (3) one 250 mg tetracycline capsule plus one placebo tablet four times daily; and (4) one placebo tablet and one placebo capsule four times daily. Sixty patients completed the 8-week study. The mean percent improvement in the groups treated with ibuprofen and tetracycline (56{\%} ± 5 SE), ibuproten alone (26{\%} ± 13 SE), or tetracycline alone (26{\%} ± 9 SE) was statistically significant. However, only the combination of ibuprofen and tetracycline therapy had an effect statistically better than the placebo response (16{\%} ± 11 SE). Adverse effects were transient and were similar in all four groups.",
author = "Wong, {R. C.} and Sewon Kang and Heezen, {J. L.} and Voorhees, {J. J.} and Ellis, {C. N.}",
year = "1984",
doi = "10.1016/S0190-9622(84)80192-9",
language = "English (US)",
volume = "11",
pages = "1076--1081",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Oral ibuprofen and tetracycline for the treatment of acne vulgaris

AU - Wong, R. C.

AU - Kang, Sewon

AU - Heezen, J. L.

AU - Voorhees, J. J.

AU - Ellis, C. N.

PY - 1984

Y1 - 1984

N2 - A prospective evaluation of the efficacy and safety of oral ibuprofen and tetracycline hydrochloride was conducted for 8 weeks in patients with moderately severe acne. Sixty-eight patients were randomly assigned in a double-blind fashion to one of four regimens: (1) one 600 mg ibuprofen tablet plus one 250 mg tetracycline capsule four times daily; (2) one 600 mg ibuprofen tablet plus one placebo capsule four times daily; (3) one 250 mg tetracycline capsule plus one placebo tablet four times daily; and (4) one placebo tablet and one placebo capsule four times daily. Sixty patients completed the 8-week study. The mean percent improvement in the groups treated with ibuprofen and tetracycline (56% ± 5 SE), ibuproten alone (26% ± 13 SE), or tetracycline alone (26% ± 9 SE) was statistically significant. However, only the combination of ibuprofen and tetracycline therapy had an effect statistically better than the placebo response (16% ± 11 SE). Adverse effects were transient and were similar in all four groups.

AB - A prospective evaluation of the efficacy and safety of oral ibuprofen and tetracycline hydrochloride was conducted for 8 weeks in patients with moderately severe acne. Sixty-eight patients were randomly assigned in a double-blind fashion to one of four regimens: (1) one 600 mg ibuprofen tablet plus one 250 mg tetracycline capsule four times daily; (2) one 600 mg ibuprofen tablet plus one placebo capsule four times daily; (3) one 250 mg tetracycline capsule plus one placebo tablet four times daily; and (4) one placebo tablet and one placebo capsule four times daily. Sixty patients completed the 8-week study. The mean percent improvement in the groups treated with ibuprofen and tetracycline (56% ± 5 SE), ibuproten alone (26% ± 13 SE), or tetracycline alone (26% ± 9 SE) was statistically significant. However, only the combination of ibuprofen and tetracycline therapy had an effect statistically better than the placebo response (16% ± 11 SE). Adverse effects were transient and were similar in all four groups.

UR - http://www.scopus.com/inward/record.url?scp=0021738539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021738539&partnerID=8YFLogxK

U2 - 10.1016/S0190-9622(84)80192-9

DO - 10.1016/S0190-9622(84)80192-9

M3 - Article

C2 - 6239884

AN - SCOPUS:0021738539

VL - 11

SP - 1076

EP - 1081

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 6

ER -